These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 12675893

  • 1. Molecular mechanisms of lipid disorders in nephrotic syndrome.
    Vaziri ND.
    Kidney Int; 2003 May; 63(5):1964-76. PubMed ID: 12675893
    [No Abstract] [Full Text] [Related]

  • 2. Increased high density lipoprotein cholesterol in adult nephrotic syndrome in Nigeria.
    Adigun MO, Agbedana EO, Kadiri S, Taylor GO.
    Afr J Med Med Sci; 1999 May; 28(1-2):97-100. PubMed ID: 12953996
    [Abstract] [Full Text] [Related]

  • 3. [Lipid metabolism in daunomycin-induced nephrotic rats (Part 6)].
    Gomikawa S, Inagaki O, Mori H, Inoue S, Takamitsu Y, Fujita Y.
    Nihon Jinzo Gakkai Shi; 1993 Mar; 35(3):239-46. PubMed ID: 8501853
    [Abstract] [Full Text] [Related]

  • 4. [About two cases of massive hypercholesterolemia].
    Perier C, Raby N, Atieh S, Granouillet R, Chamson A.
    Ann Biol Clin (Paris); 2005 Mar; 63(2):217-9. PubMed ID: 15771981
    [Abstract] [Full Text] [Related]

  • 5. [Lipid disturbances in the nephrotic syndrome].
    Chmielewski M, Zdrojewski Z, Rutkowski B.
    Przegl Lek; 2003 Mar; 60(11):758-61. PubMed ID: 15058052
    [Abstract] [Full Text] [Related]

  • 6. [Molecular mechanism of fatty acids impact on plasma lipid profile (part I)].
    Swierczyński J, Wołyniec W, Chmielewski M, Rutkowski B.
    Przegl Lek; 2007 Mar; 64(1):37-41. PubMed ID: 18183830
    [Abstract] [Full Text] [Related]

  • 7. [Hyperlipidemia in nephrotic syndrome].
    Heaf JG.
    Ugeskr Laeger; 1991 Aug 26; 153(35):2414-6. PubMed ID: 1949240
    [Abstract] [Full Text] [Related]

  • 8. [Modification of lipoprotein metabolism. A new era].
    Masana Marín L.
    Rev Clin Esp; 1990 Mar 26; 186(4):149-50. PubMed ID: 2367714
    [No Abstract] [Full Text] [Related]

  • 9. [Comparative study of lipid metabolism in ischemic heart disease and nephrotic syndrome].
    Dzhumaev DS, Shcherbakova IA, Titov VN.
    Kardiologiia; 1976 Aug 26; 16(8):122-5. PubMed ID: 189118
    [No Abstract] [Full Text] [Related]

  • 10. Mechanisms of disease: HDL metabolism as a target for novel therapies.
    Rader DJ.
    Nat Clin Pract Cardiovasc Med; 2007 Feb 26; 4(2):102-9. PubMed ID: 17245404
    [Abstract] [Full Text] [Related]

  • 11. [Metabolism of magnesium and lipid disturbances in chronic renal failure].
    Fijałkowska-Morawska J, Chrzanowski W.
    Pol Arch Med Wewn; 1997 Oct 26; 98(10):327-31. PubMed ID: 9557087
    [No Abstract] [Full Text] [Related]

  • 12. Characteristics of lipid metabolism under different urinary protein excretion in children with primary nephrotic syndrome.
    Hu P, Lu L, Hu B, Du PF.
    Scand J Clin Lab Invest; 2009 Oct 26; 69(6):680-6. PubMed ID: 19468931
    [Abstract] [Full Text] [Related]

  • 13. Abnormalities of lipoprotein metabolism in patients with the nephrotic syndrome.
    Joven J, Villabona C, Vilella E, Masana L, Albertí R, Vallés M.
    N Engl J Med; 1990 Aug 30; 323(9):579-84. PubMed ID: 2381443
    [Abstract] [Full Text] [Related]

  • 14. [Pathogenesis of atherosclerosis in patients with lipid metabolism disturbances: hypothesis on cholesterol utilization and atheromatous plaque formation].
    Chepelenko GV.
    Angiol Sosud Khir; 2003 Aug 30; 9(3):20-5. PubMed ID: 14657928
    [Abstract] [Full Text] [Related]

  • 15. [Characteristics of lipoprotein metabolism impairments in nephrotic syndrome].
    Titov VN, Tvorogova MG, Levitova EN, Krylova EA.
    Vopr Med Khim; 1983 Aug 30; 29(2):17-23. PubMed ID: 6858031
    [Abstract] [Full Text] [Related]

  • 16. Visceral leishmaniasis is associated with marked changes in serum lipid profile.
    Liberopoulos EN, Apostolou F, Gazi IF, Kostara C, Bairaktari ET, Tselepis AD, Elisaf M.
    Eur J Clin Invest; 2014 Aug 30; 44(8):719-27. PubMed ID: 24920396
    [Abstract] [Full Text] [Related]

  • 17. [Gemfibrozil in the differential therapy of disorders of fat metabolism].
    Ebner F.
    Fortschr Med; 1992 Oct 10; 110(28):523-6. PubMed ID: 1398412
    [Abstract] [Full Text] [Related]

  • 18. [Effects of hypothyroidism on plasma lipoprotein metabolism].
    Hayashi H.
    Nihon Rinsho; 2001 Mar 10; 59 Suppl 3():172-6. PubMed ID: 11347052
    [No Abstract] [Full Text] [Related]

  • 19. Hypocholesterolemic effect of spirulina in patients with hyperlipidemic nephrotic syndrome.
    Samuels R, Mani UV, Iyer UM, Nayak US.
    J Med Food; 2002 Mar 10; 5(2):91-6. PubMed ID: 12487756
    [Abstract] [Full Text] [Related]

  • 20. APOE gene polymorphisms and response to statin therapy.
    Zintzaras E, Kitsios GD, Triposkiadis F, Lau J, Raman G.
    Pharmacogenomics J; 2009 Aug 10; 9(4):248-57. PubMed ID: 19529002
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.